SIGA Technologies Inc
SIGA6.540USD
-1.630-19.95%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
468.34MMarket Cap
6.29P/E TTM
More Details of SIGA Technologies Inc Company
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.
SIGA Technologies Inc Info
Ticker SymbolSIGA
Company nameSIGA Technologies Inc
IPO dateSep 09, 1997
CEODr. Diem Nguyen, Ph.D.
Number of employees46
Security typeOrdinary Share
Fiscal year-endSep 09
Address31 East 62Nd Street
CityNEW YORK
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code10065
Phone12126729100
Websitehttps://www.siga.com/
Ticker SymbolSIGA
IPO dateSep 09, 1997
CEODr. Diem Nguyen, Ph.D.
Company Executives of SIGA Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+4.50%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+12.87%
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
71.87K
+22.83%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
67.65K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+30.70%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
--
--
Suzanne Harnett
Suzanne Harnett
Senior Vice President - Corporate Affairs and Investor Relations
Senior Vice President - Corporate Affairs and Investor Relations
--
--
Mr. Lawrence R. (Larry) Miller
Mr. Lawrence R. (Larry) Miller
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Harold E. Ford, Jr.
Mr. Harold E. Ford, Jr.
Independent Director
Independent Director
--
--
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+4.50%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+12.87%
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
71.87K
+22.83%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
67.65K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+30.70%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
No Data
By RegionUSD
Name
Revenue
Proportion
United States
81.12M
0.00%
Canada
0.00
0.00%
Europe, Middle East and Africa (EMEA)
0.00
0.00%
Asia Pacific
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Nov 1
Updated: Sat, Nov 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
MacAndrews & Forbes Holdings, Inc.
33.73%
Lewis (John Latane IV)
7.36%
BlackRock Institutional Trust Company, N.A.
4.04%
The Vanguard Group, Inc.
3.66%
AltraVue Capital, LLC.
3.49%
Other
47.72%
Shareholders
Shareholders
Proportion
MacAndrews & Forbes Holdings, Inc.
33.73%
Lewis (John Latane IV)
7.36%
BlackRock Institutional Trust Company, N.A.
4.04%
The Vanguard Group, Inc.
3.66%
AltraVue Capital, LLC.
3.49%
Other
47.72%
Shareholder Types
Shareholders
Proportion
Holding Company
33.74%
Investment Advisor
21.37%
Investment Advisor/Hedge Fund
20.58%
Individual Investor
9.58%
Hedge Fund
3.90%
Pension Fund
1.43%
Research Firm
1.39%
Bank and Trust
0.21%
Insurance Company
0.01%
Other
7.80%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
367
35.40M
49.44%
-5.13M
2025Q2
371
67.74M
94.60%
-3.85M
2025Q1
373
68.25M
95.72%
+20.84M
2024Q4
383
67.66M
94.75%
+19.97M
2024Q3
383
69.27M
97.02%
+23.98M
2024Q2
372
66.53M
93.22%
+21.86M
2024Q1
353
41.88M
58.83%
-3.74M
2023Q4
341
41.95M
58.96%
-4.28M
2023Q3
343
42.34M
59.51%
-1.31M
2023Q2
346
70.75M
97.35%
-304.51K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
MacAndrews & Forbes Holdings, Inc.
24.16M
33.74%
--
--
Apr 17, 2025
Lewis (John Latane IV)
5.27M
7.36%
--
--
Apr 17, 2025
BlackRock Institutional Trust Company, N.A.
2.89M
4.04%
-259.97K
-8.25%
Jun 30, 2025
The Vanguard Group, Inc.
2.48M
3.46%
-7.21K
-0.29%
Jun 30, 2025
AltraVue Capital, LLC.
2.50M
3.49%
+104.19K
+4.35%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.41M
3.36%
+54.60K
+2.32%
Jun 30, 2025
Hotchkis and Wiley Capital Management, LLC
2.07M
2.89%
-1.09M
-34.53%
Jun 30, 2025
American Century Investment Management, Inc.
1.41M
1.96%
+34.51K
+2.52%
Jun 30, 2025
Citadel Advisors LLC
1.39M
1.95%
+233.68K
+20.13%
Jun 30, 2025
State Street Investment Management (US)
1.11M
1.55%
+2.59K
+0.23%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Cambria Micro and SmallCap Shareholder Yield ETF
1.29%
Janus Henderson Small Cap Growth Alpha ETF
1.06%
Acquirers Small and Micro Deep Value ETF
1.06%
First Trust Dow Jones Select MicroCap Index Fund
0.59%
Lattice Hartford Multifactor Small Cap ETF
0.57%
Invesco NASDAQ Future Gen 200 ETF
0.53%
Royce Quant Small-Cap Quality Value ETF
0.52%
Hypatia Women CEO ETF
0.52%
First Trust Active Factor Small Cap ETF
0.45%
ALPS Barron's 400 ETF
0.26%
View more
Cambria Micro and SmallCap Shareholder Yield ETF
Proportion1.29%
Janus Henderson Small Cap Growth Alpha ETF
Proportion1.06%
Acquirers Small and Micro Deep Value ETF
Proportion1.06%
First Trust Dow Jones Select MicroCap Index Fund
Proportion0.59%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.57%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.53%
Royce Quant Small-Cap Quality Value ETF
Proportion0.52%
Hypatia Women CEO ETF
Proportion0.52%
First Trust Active Factor Small Cap ETF
Proportion0.45%
ALPS Barron's 400 ETF
Proportion0.26%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
